INTRODUCTION
============

Hepatitis A virus (HAV) constitutes the major cause of acute hepatitis throughout the world and causes substantial morbidity in both developed and developing countries ([@b10]). Although the role of the HAV in the acute hepatitis outbreaks in industrialized countries was established ([@b3]--[@b4], [@b18]--[@b19], [@b23]), little is known about its contribution to the occurring outbreaks in the developing countries.

Our studies conducted previously in Tunisia during the period from 2000 to 2004 ([@b8]) showed the prevalence of HAV in waste water and shellfish samples with clear predominance of sub-genotype IA in blood samples from seropositive patients ([@b7]). As far as we know, no clear evidence of well-water-associated HAV outbreaks has been reported in Tunisia. The severity of HAV infection is multi-factorial with age, gender, and drug toxicity. Many socio-economical factors play an important role in reducing hepatitis incidence in Tunisia ([@b11], [@b16]) and some Tunisian urban regions are now considered as areas of moderate endemicity pattern of HAV seroprevalence ([@b11]). Nevertheless,in some regions with low socio-economic conditions, some people still use well-water as a drinking water supply and the consumption of such water may contribute to several infections.

HAV, member of the genus Hepatovirus of the *Picornaviridae* family, is transmitted primarily through the fecal-oral route ([@b14]). The nucleotide analysis of the VP1/2A junction classified HAV in six different genotypes (I-VI) and six sub-genotypes (IA, IB, IIA, IIB, IIIA, and IIIB) ([@b13], [@b17]). Sequence diversity among genotypes was estimated to 15--25% ([@b17]).

Costa-Mattioli et al. ([@b5]) investigated the genetic variability of HAV strains using the complete sequences of VP1 gene. The obtained results revealed the existence of five groups or genotypes (I, III, IV, V, and VII). Based upon the VP1/2A junction and the complete genome sequences, Lu et al. ([@b13]) proposed to re-classify genotype VII (SLF88) and genotype II (CF53/Berne) to sub-genotypes IIB and IIA, respectively. Molecular characterization and nucleotide sequence comparison during HAV outbreaks may provide a deep insight into the molecular epidemiology of the prevalent HAV strains.

In the present study, an HAV outbreak in five Tunisian childcare centers in a sub-urban area of El-Mahres (governorate of Sfax, south of Tunisia) between October and December 2006 was reported. Molecular studies were conducted to characterize the detected HAV isolates.

MATERIALS AND METHODS
=====================

Survey design and case definition
---------------------------------

El-Mahres is a suburban region in the south of Tunisia with moderate to low socio-economic conditions. An HAV outbreak in five childcare centers was registered in this region during the period from October to December 2006. An interview was performed to examine the available medical and epidemiological information. A questionnaire was carried out according to the Tunisian Ministry of Health Regulations. Stool and serum samples from children (n=50) under 6 years old with acute hepatitis were collected. Five well-water samples from different wells in the region and five drinking water samples from the five childcare centers were included for analysis. Actual case (AC) was identified by the presence of clinical signs and anti-HAV IgM seropositive. A total of 50 stool, 50 serum, 5 well-water, and 5 drinking-water samples were collected. Informed consent was obtained from all patients.

Biochemical and serological analysis
------------------------------------

The alanine aminotransferase (ALT) blood test is typically used to detect liver injury. It is often ordered in conjunction with aspartate aminotransferase (AST) or as part of a liver panel to help diagnose liver disease. The normal level of ALT is assumed to be 4-36 U/L. Very high ALT levels (more than 10 times the highest normal level) are usually due to acute hepatitis, often due to a virus infection.

In acute hepatitis, ALT levels usually keep high for about 1-2 months but can take as long as 3-6 months to return to its normal level. The serum samples were screened for the presence of ALT by biochemical tests according to the manufacturer's instructions. Anti-HAV IgM enzyme immunoassay was carried out using a diagnosis kit for HAV IgM antibody according to the manufacturer's instructions (Abbott Laboratories, Rungies, France).

Virus concentration and RNA extraction
--------------------------------------

HAV was concentrated from the water samples using the method described by the US Environmental Protection Agency ([@b6]). Samples were diluted with 1% (v ⁄ v) of 0.05 M aluminium chloride and the pH was then adjusted to 3.5. The mixture was homogenized and centrifuged at 2 500 x g for 15 min. The pellet was suspended in 100 mL of 10% beef extract (w ⁄ v) (Oxoid, Basingstoke, UK) and adjusted to pH 7.0. The mixture was again homogenized and centrifuged at 10 000 x g for 30 min. The extraction of viral RNA from stool and water samples was carried out using QIAamp viral RNA kit according to the manufacturer's instructions (Qiagen, Paris, France). Viral RNA was stored at -80°C until use or used immediately.

RT-PCR and gel electrophoresis
------------------------------

Viral RNA was amplified using specific primers for entire VP1 and VP1/2A junction (1070 bp) as described previously ([@b5]). Reverse-transcription polymerase chain reaction (RT-PCR) was performed using Qiagen OneStep RT-PCR kit according to the manufacturer's instructions (Qiagen, Paris, France).

RT-PCR products were resolved by gel electrophoresis on 2% agarose gel in TBE (Tris--boric acid--EDTA) buffer and stained by ethidium bromide (Sigma, NY, USA). The product of the RT-PCR was visualized using UV transilluminator and gel images were recorded digitally with the Gel Doc 2000 system (Bio-Rad Laboratories, NY, USA).

Cloning and sequencing of the amplified fragment
------------------------------------------------

RT-PCR products from stool and water samples collected in the present work were purified by phenol--chloroform extraction ([@b22]). DNA fragments were ligated directly into the pMOSBlue-T vector (Amersham, Les Ullis, France) using a blunt-ended cloning kit (Amersham). These plasmids were then used to transform *Escherichia coli* pMOSBlue-competent cells, prepared as described by Tounsi *et al.* ([@b22]) using a method based on the conventional calcium chloride method. Plasmid DNA was extracted using the rapid alkaline extraction procedure described by Birnboim and Doly ([@b1]). DNA sequencing was carried out using ABI Prism BigDye Terminator cycle sequencing ready reaction kit and 373A DNA sequencing system (Applera Corporation, Forster City, CA).

Phylogenetic analysis
---------------------

Nucleotide sequences of HAV strains and isolates were included for phylogenetic analysis ([Table 1](#tbl1){ref-type="table"}). Sequence alignment and analysis were performed using FASTA software (version 3), ClustalW software ([@b21]), and MEGA 4.0 program ([@b20]).

###### 

Nucleotide sequences of HAV reference strains and Tunisian isolates included for phylogenetic analysis

  Strains                                        Accession numbers   Year   Sequence         Sub-genotype   References
  ---------------------------------------------- ------------------- ------ ---------------- -------------- ------------
  HM-175                                         M1 4707                    VP1 and VP1/2A   IB             
  GBM                                            X75215                     VP1 and VP1/2A   IA             
  Tun105--01                                     AY875657            2001   VP1 and VP1/2A   IA             [@b8]
  TunS3--01                                      AY875663                   VP1 and VP1/2A   IA             
  TunS4--01                                      AY875664                   VP1 and VP1/2A   IA             
  Tun 102--01                                    AY875672                   VP1 and VP1/2A   IA             
  Tun1 13--02                                    AY875652            2002   VP1 and VP1/2A   IA             [@b8]
  Tun159--02                                     AY875656                   VP1 and VP1/2A   IB, IA         
  Tun1 16--02                                    AY875661                   VP1 and VP1/2A   IA             
  Tun40--03[^s^](#tf1-1){ref-type="table-fn"}    AY875649            2003   VP1 and VP1/2A   IA             [@b8]
  Tun148--03                                     AY875650                   VP1 and VP1/2A   IA             
  Tun 165--03                                    AY875651                   VP1 and VP1/2A   IA             
  Tun153--03                                     AY875653                   VP1 and VP1/2A   IA             
  Tun29--03[^s^](#tf1-1){ref-type="table-fn"}    AY875654                   VP1 and VP1/2A   IA             
  Tun97--03                                      AY875655                   VP1 and VP1/2A   IA             
  Tun92--03                                      AY875658                   VP1 and VP1/2A   IB             
  Tun 143--03                                    AY875659                   VP1 and VP1/2A   IA             
  Tun 15 2--03                                   AY875660                   VP1 and VP1/2A   IA             
  Tun147--03                                     AY875662                   VP1 and VP1/2A   IA             
  Tun25--03[^s^](#tf1-1){ref-type="table-fn"}    AY875665                   VP1 and VP1/2A   IA             
  Tun18--03[^s^](#tf1-1){ref-type="table-fn"}    AY875666                   VP1 and VP1/2A   IA             
  Tun27--03[^s^](#tf1-1){ref-type="table-fn"}    AY875667                   VP1 and VP1/2A   IA             
  Tun77--03                                      DQ380523                   VP1 and VP1/2A   IA             [@b8]
  Tun49--03                                      DQ380510                   VP1 and VP1/2A   IA             [@b10]
  Tun 1--03                                      DQ380511                   VP1 and VP1/2A   IA             
  Tun 17--03                                     DQ380512                   VP1 and VP1/2A   IA             
  Tun 19--03                                     DQ380513                   VP1 and VP1/2A   IA             
  Tun42--03                                      DQ380514                   VP1 and VP1/2A   IA             
  Tun62--03                                      DQ380515                   VP1 and VP1/2A   IA             
  Tun75--03                                      DQ380516                   VP1 and VP1/2A   IA             
  Tun66--03                                      DQ380517                   VP1 and VP1/2A   IA             
  Tun28--03                                      DQ380518                   VP1 and VP1/2A   IA             
  Tun36--03                                      DQ380519                   VP1 and VP1/2A   IA             
  Tun70--03                                      DQ380520                   VP1 and VP1/2A   IA             
  Tun80--03                                      DQ380521                   VP1 and VP1/2A   IA             
  Tun79--03                                      DQ380522                   VP1 and VP1/2A   IA             
  Tun216--04[^s^](#tf1-1){ref-type="table-fn"}   AY875668            2004   VP1 and VP1/2A   IA             [@b8]
  Tun225--04[^s^](#tf1-1){ref-type="table-fn"}   AY875669                   VP1 and VP1/2A   IA             
  Tun228--04[^s^](#tf1-1){ref-type="table-fn"}   AY875670                   VP1 and VP1/2A   IA             
  Tun295--04                                     AY875671                   VP1 and VP1/2A   IA             

HAV strains detected in the same region (Sfax) as the outbreak isolates.

Plot similarity was carried out using Simplot, version 3.5.1 ([@b12]).

The evolutionary history of the sequences was inferred using the UPGMA method. The tree was drawn to scale, with the branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Maximum Composite Likelihood method and are in the units of the number of base substitutions per site. All the positions containing gaps and missing data were eliminated from the dataset (complete deletion option).

RESULTS
=======

Serological and biochemical analysis
------------------------------------

A total of 100 stool and serum samples were collected. The patients showed acute hepatitis including jaundice, nausea, fever, vomiting, and abdominal pain. The results of ALT test in children's blood with acute hepatitis showed high levels of ALT. Anti-HAV IgM was detected in all children.

DNA sequencing and phylogenetic analysis
----------------------------------------

The HAV genome fragment with a size of 1070 nucleotides of the entire VP1 and VP1/2A junction region was amplified by RT-PCR ([@b5]). Although HAV RNA was detected in all the stool and well-water samples, it was not detected in the five drinking water samples.

Fifteen HAV isolates were selected and their nucleotide sequences were deposited in GenBank under accession numbers HM011106, HM011107, HM011108, HM011109, HM011110, HM011111, HM011112, HM011113, HM011114, HM011115, HM011116, HM011117, HM011118, HM011119, and HM011120. Sequence analysis showed high similarity (99%) among HAV strains isolated in stool and well-water samples.

Fifteen HAV isolates were selected and their nucleotide sequences were deposited in GenBank under accession numbers HM011106, HM011107, HM011108, HM011109, HM011110, HM011111, HM011112, HM011113, HM011114, HM011115, HM011116, HM011117, HM011118, HM011119, and HM011120. Sequence analysis showed high similarity (99%) among HAV strains isolated in stool and well-water samples.

The phylogenetic analysis classified the detected isolates into sub-genotype IA ([Figure 1, C](#fig1){ref-type="fig"}). The detected HAV isolate in well-water (Tun15--2006W) was clustered with the clinical strains ([Figure 1, A](#fig1){ref-type="fig"}).

![Phylogenetic analysis. Phylogenetic tree of HAV strains and Tunisian HAV strains isolated from 2001 to 2006. The entire VP1 and VP1/2A nucleotide sequences were analyzed using UPGMA bootstrap test of phylogeny. The number at nodes indicates bootstrap percentages after 1,000 replicate sampling. The bar indicates genetic distance and values under 70% were hidden. Cut-off value for condensed tree is 50%. A: The Tunisian HAV strains detected in the present work; B: HAV strains genotype IB; and C: HAV strains genotype IA.](bjm-42-1204-g001){#fig1}

For plot similarity analysis, HAV isolate Tun1--2006 was used as a sequence query. Plot of similarity showed a high similarity among all Tunisian HAV isolates and the reference strain GBM (sub-genotype IA, accession number X75215) ([Figure 2](#fig2){ref-type="fig"}, A). The exception was for HAV isolates Tun159--02 (sub-genotype IB, IA, accession number AY875656), and Tun92--03 (sub-genotype IB, accession number AY875658). These strains are classified with the reference strain HM-175 (sub-genotype IB, accession number M14707) ([Figure 2](#fig2){ref-type="fig"}).

![Plot Analysis.\
Plot of nucleotide similarity (generated by SimPlot) of a set of HAV reference sequences and Tunisian strains isolated previously to the Tun1--2006. Each point plotted is the percent identity within a sliding window of 200 bp, with a step size between points of 20 bp. Positions containing gaps were excluded from the comparison. A: outbreak isolates and previously detected Tunisian HAV isolates grouped in a cluster. The accession numbers of HAV type strain HM-175 (genotype IB), Tunisian HAV isolates Tun159--02 (accession number AY875656, genotype IB/IA), Tunisian HAV isolate Tun92--03 (accession number AY875658, genotype IB), and Tunisian HAV isolate Tun105--01 (accession number AY875657, genotype IA) are shown. The cross position between Tun159--02 and reference type HM-175 is indicated by a vertical line in position 641.](bjm-42-1204-g002){#fig2}

Simplot analysis showed further characteristics of HAV isolate Tun159--02 (Blue line) detected and characterized previously as genotype IA and IB ([@b7]). A cross point at position 641 showed a recombination event between co-circulating HAV strains of different genotypes. Furthermore, HAV strains Tun92--03 (genotype IB, gray line) and Tun105--01 (genotype IA, green line) showed cross events between genotypes in positions 470--700 and 400--600, respectively.

One nucleotide substitution in the VP1/2A junction of the HAV outbreak isolates has modified the amino acid sequence at the position 291 (Arg \> Lys) ([Figure 3](#fig3){ref-type="fig"}). At this amino acid position, the HAV isolates detected in the present work seem to be more related to genotype IB. This substitution was absent in the HAV isolates detected previously in Tunisia. These findings arise an important question about the source of such circulating strains.

Epidemiologic studies conducted later by investigators in the region of Sfax did not support the emergence of new HAV variant with the same profile as for the strains detected in the present study (unpublished data). Further studies need to be conducted to further characterize the emergent HAV strains in the country from clinic and environment samples.

The analysis of the deduced amino acid sequences showed that HAV Tun11--2006 and Tun8--2006 strains are distinguished from the other outbreak isolates by two amino acids in positions 270 and 281, respectively. HAV strains Tun11--2006 and Tun8--2006 may be more related to Tunisian HAV strains Tun62--03 and Tun143--03 under accession numbers DQ380515 and AY875659, respectively ([Figure 3](#fig3){ref-type="fig"}).

![Alignment of the deduced amino acid sequences of the entire VP1 and VP1/2A junction of HAV strains and Tunisian isolates. Consensus sequence was generated for HAV strain and isolates. Amino acid sequences of the Tunisian HAV strains detected in the present study are shown in bold. Amino acid sequences from 61 to 240 showed high degree of similarity and were excluded from the figure.](bjm-42-1204-g003){#fig3}

DISCUSSION
==========

Although many outbreaks in childcare centers associated with foods, water, and person-to-person were described previously in USA, China, and Thailand ([@b2], [@b15], [@b17], [@b23]), HAV transmission by water in Tunisia is probably underestimated since outbreaks appear to be infrequently reported, poorly documented, and the virus has rarely been isolated from this source.

The present study constituted an epidemiologic survey and molecular studies of an HAV outbreak among children under six years old. Data obtained in the present study showed the consumption of contaminated water by patients during the period of September 2006 which was marked by a high level of precipitation in the region.

Molecular epidemiologic studies conducted in the region after the outbreak period (in 2007) did not reveal any significant epidemiologic peculiarities and the nucleotide sequences of the positive samples were more related to Tunisian strains detected previously (2001--2004) (unpublished data).

The present work showed that although its incidence has declined over the past decades, HAV outbreaks continue to occur in Tunisia. The HAV isolates identified during this outbreak were clustered within sub-genotype IA as the most HAV isolates detected previously in Tunisia ([@b7]--[@b9]).

Our finding emphasizes the importance of the epidemiological studies and the molecular characterization of the emergent HAV strains.

Sequence analysis of the detected HAV isolates supported the evolutionary approach of HAV in Tunisia ([@b9]). Nevertheless, further studies need to be conducted to evaluate the prevalence of new HAV variants in the Tunisian population and in the environment.
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